Gregory Davis, DPM
Foot & Ankle Surgery · Columbia, SCNPI 1962599860
Payments from drug & device makers
Across 48 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$251
- Paratek Pharmaceuticals, Inc.$219
- Averitas Pharma Inc.$109
- Amgen$71
- Nabriva Therapeutics, PLC$66
- Kerecis Limited$46
- plus $272 from 12 others
What the payments were for
- Food & beverage$1,035100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 8 | $251 |
| Paratek Pharmaceuticals, Inc. | 13 | $219 |
| Averitas Pharma Inc. | 4 | $109 |
| Amgen(2 entities) | 3 | $71 |
| Nabriva Therapeutics, PLC | 3 | $66 |
| Kerecis Limited | 2 | $46 |
| Abbott | 2 | $39 |
| Globus Medical | 1 | $32 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| Fidia Pharma USA Inc. | 2 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Treace Medical Concepts, Inc. | 1 | $21 |
| Zimvie Inc. | 1 | $21 |
| Bioventus LLC | 1 | $21 |
| Mimedx Group, Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Sebela Pharmaceuticals Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $12 |
How this compares
$1,035 in reported general payments places this provider in the 25th percentile of 87 foot & ankle surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 110 | $1,158 |
| Pregabalin | 101 | $996 |
| Colchicine | 17 | $910 |
| Ammonium Lactate | 47 | $731 |
| Silver Sulfadiazine | 63 | $392 |
| Doxycycline Hyclate | 58 | $371 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $366 |
| Celecoxib | 27 | $347 |
| Triamcinolone Acetonide | 14 | $142 |
| Allopurinol | 14 | $133 |
| Mupirocin | 22 | $131 |
| SsdSilver Sulfadiazine | 19 | $119 |
| Methylprednisolone | 19 | $113 |
| Terbinafine Hcl | 17 | $89 |
| Meloxicam | 27 | $66 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Columbia
- Tyler GonzalezColumbia$525K
- William JamesColumbia$222K
- Carly ChapmanColumbia$3K
- Brandon BrooksColumbia$2K
- Christopher GrossCharleston$830K
- Benjamin OverleyHilton Head Island$643K
- Alison GartenRock Hill$419K
- Robert KleinGreenville$380K
- William HarrisLancaster$203K
- Alexander PappasMyrtle Beach$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.